Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice

AIM: Aliskiren (ALK) is a renin inhibitor that has been used in the treatment of hypertension. The aim of this study was to determine whether ALK could ameliorate pressure overload-induced heart hypertrophy and fibrosis, and to elucidate the mechanisms of action. METHODS: Transverse aortic constrict...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Weng, Li-qing, Zhang, Wen-bin, Ye, Yong, Yin, Pei-pei, Yuan, Jie, Wang, Xing-xu, Kang, Le, Jiang, Sha-sha, You, Jie-yun, Wu, Jian, Gong, Hui, Ge, Jun-bo, Zou, Yun-zeng
פורמט: Artigo
שפה:Inglês
יצא לאור: Nature Publishing Group 2014
נושאים:
Original Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4125714/
https://ncbi.nlm.nih.gov/pubmed/24998254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2014.45
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים